189 related articles for article (PubMed ID: 16537684)
1. The role of endogenous growth hormone-releasing hormone in acromegaly.
Dimaraki EV; Chandler WF; Brown MB; Jaffe CA; Kim SY; Taussig R; Padmanabhan V; Barkan AL
J Clin Endocrinol Metab; 2006 Jun; 91(6):2185-90. PubMed ID: 16537684
[TBL] [Abstract][Full Text] [Related]
2. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.
Jaffe CA; DeMott-Friberg R; Frohman LA; Barkan AL
J Clin Endocrinol Metab; 1997 Feb; 82(2):634-7. PubMed ID: 9024267
[TBL] [Abstract][Full Text] [Related]
4. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
6. The control on growth hormone release by free fatty acids is maintained in acromegaly.
Lanzi R; Losa M; Mignogna G; Caumo A; Pontiroli AE
J Clin Endocrinol Metab; 1999 Apr; 84(4):1234-8. PubMed ID: 10199760
[TBL] [Abstract][Full Text] [Related]
7. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y
J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.
Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G
Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448
[TBL] [Abstract][Full Text] [Related]
9. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
van der Klaauw AA; Pereira AM; van Thiel SW; Smit JW; Corssmit EP; Biermasz NR; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
Eur J Endocrinol; 2006 Jun; 154(6):851-8. PubMed ID: 16728545
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
Ho PJ; Friberg RD; Barkan AL
J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
[TBL] [Abstract][Full Text] [Related]
11. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
Racine MS; Symons KV; Foster CM; Barkan AL
J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
19. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.
Pandya N; DeMott-Friberg R; Bowers CY; Barkan AL; Jaffe CA
J Clin Endocrinol Metab; 1998 Apr; 83(4):1186-9. PubMed ID: 9543138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
